Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1017: Percutaneous PFO Closure Versus Medical Therapy for Prevention of Recurrent Stroke in Patients With Cryptogenic Stroke: A Comparative Clinical Outcomes Analysis

Presenter: Mehmet Cilingiroglu

October 28, 2025

Presentation TCT 2024

TCT 311: Identifying Success Factors for Patent Foramen Ovale Closure in Cryptogenic Stroke

Presenter: Yoonsun Won

October 29, 2024

Presentation TCT 2023

Close It: Age Is Unimportant if the Cryptogenic Stroke w/u Was Negative

Presenter: David Thaler

October 26, 2023

Presentation TCT 2023

TCT 445: Almost Half of PFO Related Cryptogenic Strokes are Non-Cortical

Presenter: Mohammed Ebrahim

October 24, 2023

Presentation TCT 2022

TCT 377: Automated Robotic TCD for RLS detection in the evaluation of patients with Cryptogenic Stroke

Presenter: Ruchir Shah

September 19, 2022

Presentation TVT 2021

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Presenter: Mark Reisman

July 22, 2021

Presentation TVT 2019

Updated PFO Closure for Cryptogenic Stroke, Migraine, and More…

Presenter: Mark Reisman

June 14, 2019

Presentation TVT 2019

PFO Closure for Conditions Beyond Cryptogenic Stroke

Presenter: Thomas Jones

June 14, 2019

Presentation Cardiovascular Interventions 2018

PFO Closure to Prevent Recurrent Cryptogenic Stroke

Presenter: Matthew J. Price

October 26, 2018

Presentation TCT 2018

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

A Patient With a PFO and Cryptogenic Stroke Outside the Recommended Age Range: Is PFO Closure Appropriate?

Presenter: Zahid Amin, Robert J. Sommer, Peter C. Block, John P. Breinholt, Craig E Fleishman, Jan Kovac, Harsimran Sachdeva Singh, Christian Spies

September 24, 2018

Presentation TCT 2018

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Presenter: Teiji Akagi, John D. Carroll, Konstantinos Dean Boudoulas

September 22, 2018

Presentation TCT 2018

Case #1: Should This PFO Be Closed in a Patient With A Cryptogenic Stroke?

Presenter: Teiji Akagi, John D. Carroll, Lee N. Benson, Stefan C. Bertog, Clifford J. Kavinsky, David W.M. Muller, Francesco Pelliccia, A.J. Conrad C. Smith

September 22, 2018

Presentation The Structural Heart Disease Summit 2018

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

Presenter: John D. Carroll, Brij Maini, Lars Sondergaard

June 23, 2018

Presentation TCT 2017

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

Presenter: Lee N. Benson, Megan Coylewright, David E. Thaler

November 01, 2017

Presentation TCT 2017

PFO Closure in Cryptogenic Stroke

Presenter: David Hildick-Smith, Lars Sondergaard

October 29, 2017

Presentation SIF 2017

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Presenter: James A. Goldstein

March 09, 2017

Presentation TCT 2016

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

Presenter: Eustaquio Maria Onorato, Richard Smalling, Robert J. Sommer

November 01, 2016

Presentation TCT 2016

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Presenter: Eustaquio Maria Onorato, Richard Smalling, David E. Thaler

November 01, 2016

Presentation TCT 2016

Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved?

Presenter: John D. Carroll, David E. Thaler, Ted Feldman

November 01, 2016

Advertisement

TCT 1017: Percutaneous PFO Closure Versus Medical Therapy for Prevention of Recurrent Stroke in Patients With Cryptogenic Stroke: A Comparative Clinical Outcomes Analysis

TCT 311: Identifying Success Factors for Patent Foramen Ovale Closure in Cryptogenic Stroke

Close It: Age Is Unimportant if the Cryptogenic Stroke w/u Was Negative

TCT 445: Almost Half of PFO Related Cryptogenic Strokes are Non-Cortical

TCT 377: Automated Robotic TCD for RLS detection in the evaluation of patients with Cryptogenic Stroke

When Both Silent AF and PFO Are Discovered During a Cryptogenic Stroke Work-up, the Optimal Therapy to Prevent Stroke Recurrence Is…

Updated PFO Closure for Cryptogenic Stroke, Migraine, and More…

PFO Closure for Conditions Beyond Cryptogenic Stroke

PFO Closure to Prevent Recurrent Cryptogenic Stroke

A Patient With Atrial Fibrillation, Cryptogenic Stroke, and PFO: Watchman Despite OAC?

A Patient With a PFO and Cryptogenic Stroke Outside the Recommended Age Range: Is PFO Closure Appropriate?

Updated RCT Data for PFO Closure in All-Comers and Subgroups With Cryptogenic Stroke: How Should the Guidelines Be Updated?

Case #1: Should This PFO Be Closed in a Patient With A Cryptogenic Stroke?

Data Deliverance: Updated PFO Closure for Cryptogenic Stroke Clinical Trial Review and Guidelines

What is Appropriate Evaluation of Cryptogenic Stroke, and When is a Hypercoagulability Work-up Needed?

PFO Closure in Cryptogenic Stroke

PFO Closure for Cryptogenic Stroke Choose your Patients Well

Cryptogenic Stroke, Thrombophilia, VTE, and PFO: Do We Know What To Do?

The Neurologist as the Gatekeeper of PFO Closure in the US: What is Cryptogenic Stroke and When Do Neurologists Think PFO Closure Is Needed?

Case #2 - Introduction: Cryptogenic Stroke: Is the Foramen Ovale Involved?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content